[1]
|
Hueman, M.T., Vollmer Jr., C.M. and Pawlik, T.M. (2009) Evolving Treatment Strategies for Gallbladder Cancer. An-nals of Surgical Oncology, 16, 2101-2115. https://doi.org/10.1245/s10434-009-0538-x
|
[2]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[3]
|
Aloia, T. A., Járufe, N., Javle, M., et al. (2015) Gallbladder Cancer: Expert Consensus Statement. HPB, 17, 681-690.
https://doi.org/10.1111/hpb.12444
|
[4]
|
Kim, H.S., Park, J.W., Kim, H., et al. (2018) Optimal Surgical Treatment in Patients with T1b Gallbladder Cancer: An International Multicenter Study. Journal of Hepato-Biliary-Pancreatic Sciences, 25, 533-543.
https://doi.org/10.1002/jhbp.593
|
[5]
|
Koga, A., Watanabe, K., Fukuyama, T., Takiguchi, S. and Nakayama, F. (1988) Diagnosis and Operative Indications for Polypoid Lesions of the Gallbladder. Archives of Surgery, 123, 26-29.
https://doi.org/10.1001/archsurg.1988.01400250028003
|
[6]
|
Donald, G., Sunjaya, D., Donahue, T. and Hines, O.J. (2013) Polyp on Ultrasound: Now What? The Association between Gallbladder Polyps and Cancer. The American Sur-geon™, 79, 1005-1008.
https://doi.org/10.1177/000313481307901010
|
[7]
|
中华医学会外科学分会胆道外科学组, 中国医师协会外科医师分会胆道外科专业委员会. 胆囊癌诊断和治疗指南(2019版) [J]. 中华外科杂志, 2020, 58(4): 243-251.
|
[8]
|
Akatsu, T., Aiura, K., Shimazu, M., et al. (2006) Can Endoscopic Ultrasonography Differentiate Nonneoplastic from Neoplastic Gallbladder Polyps? Digestive Diseases and Sciences, 51, 416-421.
https://doi.org/10.1007/s10620-006-3146-7
|
[9]
|
Wiles, R., Thoeni, R.F., Barbu, S.T., et al. (2017) Management and Follow-up of Gallbladder Polyps: Joint Guidelines between the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Association for Endoscopic Surgery and Other Interventional Techniques (EAES), In-ternational Society of Digestive Surgery—European Federation (EFISDS) and European Society of Gastrointestinal En-doscopy (ESGE). European Radiology, 27, 3856- 3866. https://doi.org/10.1007/s00330-017-4742-y
|
[10]
|
Kim, M., Kim, H., Han, Y., et al. (2021) Prognostic Value of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 19-9 (CA 19-9) in Gallbladder Cancer; 65 IU/mL of CA 19-9 Is the New Cut-off Value for Prognosis. Cancers, 13, Article No. 1089. https://doi.org/10.3390/cancers13051089
|
[11]
|
Wang, Y.-F., Feng, F.-L., Zhao, X.-H., et al. (2014) Combined Detection Tumor Markers for Diagnosis and Prognosis of Gallbladder Cancer. World Journal of Gastroen-terology, 20, 4085-4092. https://doi.org/10.3748/wjg.v20.i14.4085
|
[12]
|
鲍建亨, 尚海涛, 郝成飞, 等. 术前中性粒细胞-淋巴细胞比及CA19-9对胆囊癌根治术预后判断价值[J]. 肝胆外科杂志, 2019, 27(5): 374-379.
|
[13]
|
Myongjin, K., Hongbeom, K., Youngmin, H., et al. (2021) Prognostic Value of Carcinoembryonic Anti-gen (CEA) and Carbohydrate Antigen 19-9 (CA 19-9) in Gallbladder Cancer; 65 IU/mL of CA 19-9 Is the New Cut-Off Value for Prognosis. Cancers, 13, 1089. https://doi.org/10.3390/cancers13051089
|
[14]
|
张定富, 吴秋芳, 戈长征. 肿瘤标记物CA19-9、CA242对胰腺癌转移和预后预测价值的分析[J]. 现代肿瘤医学, 2017, 25(8): 1258-1260.
|
[15]
|
Dolscheid-Pommerich, R.C., Manekeller, S., Walgenbach-Brünagel, G., et al. (2017) Clinical Perfor-mance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer Using LOCI™-Based Assays. Anticancer Research, 37, 353-359. https://doi.org/10.21873/anticanres.11329
|
[16]
|
袁波, 傅晓辉, 尹磊, 等. 联合检测肿瘤标志物对胆囊癌诊断及患者预后的价值[J]. 中华肝胆外科杂志, 2019, 25(10): 746-750.
|
[17]
|
Zhang, D., Yu, M., Xu, T. and Xiong, B. (2013) Predictive Value of Serum CEA, CA19-9 and CA125 in Diagnosis of Colorectal Liver Me-tastasis in Chinese Population. Hepato-Gastroenterology, 60, 1297-1301.
|
[18]
|
劳富娟. 肿瘤标志物联合测定在胆囊癌患者中的诊断效果及对预后的影响研究[J]. 世界最新医学信息文摘, 2017, 17(96): 178.
|
[19]
|
张永东. 血清CA199、CA242、CA125联合检测对胆囊癌患者诊断的临床价值研究[J]. 肝胆外科杂志, 2016, 24(2): 106-110.
|
[20]
|
Ma, W., Li, W., Wang, J., et al. (2020) The Clinical Role of Preoperative Serum CA19-9 and Carcinoem-bryonic Antigen (CEA) Levels in Evaluating the Resectability of Advanced Gallbladder Cancer. Medical Science Monitor, 26, e925017. https://doi.org/10.12659/MSM.925017
|
[21]
|
李皇保, 周俊, 吴晓俊, 等. 胆囊腺癌术后患者预后影响因素[J]. 中华肝胆外科杂志, 2019, 25(8): 587-591.
|
[22]
|
Hundal, R. and Shaffer, E. (2014) Gallbladder Cancer: Epidemiology and Outcome. Clinical Epidemiology, 6, 99-109.
https://doi.org/10.2147/CLEP.S37357
|
[23]
|
Bailey, K.S., Marsh, W., Daughtery, L., Hobbs, G. and Borgstrom, D. (2022) Sex Disparities in the Presentation of Gallbladder Disease. The American Surgeon™, 88, 201-204. https://doi.org/10.1177/0003134821989044
|
[24]
|
Hueman, M.T., Vollmer Jr., C.M. and Pawlik, T.M. (2009) Evolving Treatment Strategies for Gallbladder Cancer. An-nals of Surgical Oncology, 16, 2101-2115. https://doi.org/10.1245/s10434-009-0538-x
|
[25]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[26]
|
Aloia, T. A., Járufe, N., Javle, M., et al. (2015) Gallbladder Cancer: Expert Consensus Statement. HPB, 17, 681-690.
https://doi.org/10.1111/hpb.12444
|
[27]
|
Kim, H.S., Park, J.W., Kim, H., et al. (2018) Optimal Surgical Treatment in Patients with T1b Gallbladder Cancer: An International Multicenter Study. Journal of Hepato-Biliary-Pancreatic Sciences, 25, 533-543.
https://doi.org/10.1002/jhbp.593
|
[28]
|
Koga, A., Watanabe, K., Fukuyama, T., Takiguchi, S. and Nakayama, F. (1988) Diagnosis and Operative Indications for Polypoid Lesions of the Gallbladder. Archives of Surgery, 123, 26-29.
https://doi.org/10.1001/archsurg.1988.01400250028003
|
[29]
|
Donald, G., Sunjaya, D., Donahue, T. and Hines, O.J. (2013) Polyp on Ultrasound: Now What? The Association between Gallbladder Polyps and Cancer. The American Sur-geon™, 79, 1005-1008.
https://doi.org/10.1177/000313481307901010
|
[30]
|
中华医学会外科学分会胆道外科学组, 中国医师协会外科医师分会胆道外科专业委员会. 胆囊癌诊断和治疗指南(2019版) [J]. 中华外科杂志, 2020, 58(4): 243-251.
|
[31]
|
Akatsu, T., Aiura, K., Shimazu, M., et al. (2006) Can Endoscopic Ultrasonography Differentiate Nonneoplastic from Neoplastic Gallbladder Polyps? Digestive Diseases and Sciences, 51, 416-421.
https://doi.org/10.1007/s10620-006-3146-7
|
[32]
|
Wiles, R., Thoeni, R.F., Barbu, S.T., et al. (2017) Management and Follow-up of Gallbladder Polyps: Joint Guidelines between the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Association for Endoscopic Surgery and Other Interventional Techniques (EAES), In-ternational Society of Digestive Surgery—European Federation (EFISDS) and European Society of Gastrointestinal En-doscopy (ESGE). European Radiology, 27, 3856- 3866. https://doi.org/10.1007/s00330-017-4742-y
|
[33]
|
Kim, M., Kim, H., Han, Y., et al. (2021) Prognostic Value of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 19-9 (CA 19-9) in Gallbladder Cancer; 65 IU/mL of CA 19-9 Is the New Cut-off Value for Prognosis. Cancers, 13, Article No. 1089. https://doi.org/10.3390/cancers13051089
|
[34]
|
Wang, Y.-F., Feng, F.-L., Zhao, X.-H., et al. (2014) Combined Detection Tumor Markers for Diagnosis and Prognosis of Gallbladder Cancer. World Journal of Gastroen-terology, 20, 4085-4092. https://doi.org/10.3748/wjg.v20.i14.4085
|
[35]
|
鲍建亨, 尚海涛, 郝成飞, 等. 术前中性粒细胞-淋巴细胞比及CA19-9对胆囊癌根治术预后判断价值[J]. 肝胆外科杂志, 2019, 27(5): 374-379.
|
[36]
|
Myongjin, K., Hongbeom, K., Youngmin, H., et al. (2021) Prognostic Value of Carcinoembryonic Anti-gen (CEA) and Carbohydrate Antigen 19-9 (CA 19-9) in Gallbladder Cancer; 65 IU/mL of CA 19-9 Is the New Cut-Off Value for Prognosis. Cancers, 13, 1089. https://doi.org/10.3390/cancers13051089
|
[37]
|
张定富, 吴秋芳, 戈长征. 肿瘤标记物CA19-9、CA242对胰腺癌转移和预后预测价值的分析[J]. 现代肿瘤医学, 2017, 25(8): 1258-1260.
|
[38]
|
Dolscheid-Pommerich, R.C., Manekeller, S., Walgenbach-Brünagel, G., et al. (2017) Clinical Perfor-mance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer Using LOCI™-Based Assays. Anticancer Research, 37, 353-359. https://doi.org/10.21873/anticanres.11329
|
[39]
|
袁波, 傅晓辉, 尹磊, 等. 联合检测肿瘤标志物对胆囊癌诊断及患者预后的价值[J]. 中华肝胆外科杂志, 2019, 25(10): 746-750.
|
[40]
|
Zhang, D., Yu, M., Xu, T. and Xiong, B. (2013) Predictive Value of Serum CEA, CA19-9 and CA125 in Diagnosis of Colorectal Liver Me-tastasis in Chinese Population. Hepato-Gastroenterology, 60, 1297-1301.
|
[41]
|
劳富娟. 肿瘤标志物联合测定在胆囊癌患者中的诊断效果及对预后的影响研究[J]. 世界最新医学信息文摘, 2017, 17(96): 178.
|
[42]
|
张永东. 血清CA199、CA242、CA125联合检测对胆囊癌患者诊断的临床价值研究[J]. 肝胆外科杂志, 2016, 24(2): 106-110.
|
[43]
|
Ma, W., Li, W., Wang, J., et al. (2020) The Clinical Role of Preoperative Serum CA19-9 and Carcinoem-bryonic Antigen (CEA) Levels in Evaluating the Resectability of Advanced Gallbladder Cancer. Medical Science Monitor, 26, e925017. https://doi.org/10.12659/MSM.925017
|
[44]
|
李皇保, 周俊, 吴晓俊, 等. 胆囊腺癌术后患者预后影响因素[J]. 中华肝胆外科杂志, 2019, 25(8): 587-591.
|
[45]
|
Hundal, R. and Shaffer, E. (2014) Gallbladder Cancer: Epidemiology and Outcome. Clinical Epidemiology, 6, 99-109.
https://doi.org/10.2147/CLEP.S37357
|
[46]
|
Bailey, K.S., Marsh, W., Daughtery, L., Hobbs, G. and Borgstrom, D. (2022) Sex Disparities in the Presentation of Gallbladder Disease. The American Surgeon™, 88, 201-204. https://doi.org/10.1177/0003134821989044
|